The co-expression profiles for ACSL5 with a strong cluster of 3 genes across a panel of 40 breast carcinoma and 7 normal breast samples, 2 genes across a panel of 43 ovarian cancer and 10 normal ovary samples, and 111 genes across a panel of 91 lung cancer and 65 normal lung samples were uploaded to the Metacore and the top ten GO Processes were identified (S3D–S3F Fig). The gene discussed is ACSL5; the disease is breast carcinoma.